Michaelson-Cohen, R.; Cohen, M.J.; Cohen, C.; Greenberg, D.; Shmueli, A.; Lieberman, S.; Tomer, A.; Levy-Lahad, E.; Lahad, A.
Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies. Cancers 2022, 14, 6113.
https://doi.org/10.3390/cancers14246113
AMA Style
Michaelson-Cohen R, Cohen MJ, Cohen C, Greenberg D, Shmueli A, Lieberman S, Tomer A, Levy-Lahad E, Lahad A.
Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies. Cancers. 2022; 14(24):6113.
https://doi.org/10.3390/cancers14246113
Chicago/Turabian Style
Michaelson-Cohen, Rachel, Matan J. Cohen, Carmit Cohen, Dan Greenberg, Amir Shmueli, Sari Lieberman, Ariela Tomer, Ephrat Levy-Lahad, and Amnon Lahad.
2022. "Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies" Cancers 14, no. 24: 6113.
https://doi.org/10.3390/cancers14246113
APA Style
Michaelson-Cohen, R., Cohen, M. J., Cohen, C., Greenberg, D., Shmueli, A., Lieberman, S., Tomer, A., Levy-Lahad, E., & Lahad, A.
(2022). Real World Cost-Effectiveness Analysis of Population Screening for BRCA Variants among Ashkenazi Jews Compared with Family History-Based Strategies. Cancers, 14(24), 6113.
https://doi.org/10.3390/cancers14246113